Northwest & Ethical Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$251K Hold
2,000
0.01% 443
2025
Q1
$274K Hold
2,000
0.01% 432
2024
Q4
$306K Sell
2,000
-5,428
-73% -$830K 0.01% 372
2024
Q3
$1.44M Sell
7,428
-1,139
-13% -$221K 0.04% 277
2024
Q2
$1.99M Hold
8,567
0.06% 248
2024
Q1
$1.85M Buy
8,567
+6,567
+328% +$1.42M 0.05% 253
2023
Q4
$518K Buy
+2,000
New +$518K 0.02% 311
2020
Q3
Sell
-5,109
Closed -$1.37M 401
2020
Q2
$1.37M Sell
5,109
-1,530
-23% -$409K 0.06% 278
2020
Q1
$2.1M Sell
6,639
-100
-1% -$31.6K 0.12% 203
2019
Q4
$2M Sell
6,739
-5,525
-45% -$1.64M 0.09% 268
2019
Q3
$2.86M Sell
12,264
-4,166
-25% -$970K 0.14% 196
2019
Q2
$3.84M Sell
16,430
-170
-1% -$39.8K 0.19% 154
2019
Q1
$3.92M Sell
16,600
-7,764
-32% -$1.84M 0.2% 153
2018
Q4
$7.33M Buy
24,364
+9,152
+60% +$2.75M 0.43% 59
2018
Q3
$5.37M Buy
+15,212
New +$5.37M 0.34% 88
2018
Q2
Sell
-300
Closed -$82.1K 361
2018
Q1
$82.1K Hold
300
0.01% 346
2017
Q4
$95.6K Sell
300
-3,500
-92% -$1.11M 0.01% 338
2017
Q3
$1.19M Buy
3,800
+3,563
+1,503% +$1.12M 0.07% 272
2017
Q2
$91.4K Hold
237
0.01% 350
2017
Q1
$64.8K Buy
237
+100
+73% +$27.3K ﹤0.01% 373
2016
Q4
$38.9K Buy
+137
New +$38.9K ﹤0.01% 377
2015
Q3
Sell
-8,500
Closed -$3.43M 206
2015
Q2
$3.43M Buy
+8,500
New +$3.43M 0.23% 121